Twice-weekly administration of kisspeptin-54 for 8 weeks stimulates release of reproductive hormones in women with hypothalamic amenorrhea

Clinical Pharmacology and Therapeutics

Volumn 88, Issue 6, 2010, Pages 840-847

  Jayasena, C N ^a   Nijher, G M K ^a   Abbara, A ^a   Murphy, K G ^a   Lim, A ^b   Patel, D ^b   Mehta, A ^b   Todd, C ^b   Donaldson, M ^b   Trew, G H ^a   Ghatei, M A ^a   Bloom, S R ^a   Dhillo, W S ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; METASTIN; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADULT; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESENSITIZATION; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HORMONE RELEASE; HUMAN; HYPOTHALAMIC AMENORRHEA; MENSTRUAL CYCLE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AMENORRHEA; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYPOTHALAMUS; LUTEINIZING HORMONE; PILOT PROJECTS; REPRODUCTION; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 78449307913     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.204     Document Type: Article

References (32)

1. Boivin, J., Bunting, L., Collins, J.A. & Nygren, K.G. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum. Reprod. 22, 1506-1512 (2007).
2. Elchalal, U. & Schenker, J.G. The pathophysiology of ovarian hyperstimulation syndrome-views and ideas. Hum. Reprod. 12, 1129-1137 (1997).
3. Ohtaki, T. et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 411, 613-617 (2001).
4. Muir, A.I. et al. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J. Biol. Chem. 276, 28969-28975 (2001).
5. de Roux, N., Genin, E., Carel, J.c., Matsuda, F., Chaussain, J.L. & Milgrom, E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc. Natl. Acad. Sci. USA 100, 10972-10976 (2003).
6. Seminara, S.B. et al. The GPR54 gene as a regulator of puberty. N. Engl. J. Med. 349, 1614-1627 (2003).
7. Teles, M.G. et al. A GPR54-activating mutation in a patient with central precocious puberty. N. Engl. J. Med. 358, 709-715 (2008).
8. Irwig, M.S. et al. Kisspeptin activation of gonadotropin releasing hormone neurons and regulation of KiSS-1 mRNA in the male rat. Neuroendocrinology 80, 264-272 (2004).
9. Navarro, V.M. et al. developmental and hormonally regulated messenger ribonucleic acid expression of KiSS-1 and its putative receptor, GPR54, in rat hypothalamus and potent luteinizing hormone-releasing activity of KiSS-1 peptide. Endocrinology 145, 4565-4574 (2004).
10. Thompson, E.L. et al. central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J. Neuroendocrinol. 16, 850-858 (2004).
11. Gottsch, M.L. et al. A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology 145, 4073-4077 (2004).
12. Messager, S. et al. Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc. Natl. Acad. Sci. USA 102, 1761-1766 (2005).
13. Shahab, M., Mastronardi, c., Seminara, S.B., Crowley, W.F., Ojeda, S.R. & Plant, T.M. Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates. Proc. Natl. Acad. Sci. USA 102, 2129-2134 (2005).
14. Caraty, A. et al. Kisspeptin synchronizes preovulatory surges in cyclical ewes and causes ovulation in seasonally acyclic ewes. Endocrinology 148, 5258-5267 (2007).
15. Dhillo, W.S. et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J. Clin. Endocrinol. Metab. 90, 6609-6615 (2005).
16. Dhillo, W.S. et al. Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. J. Clin. Endocrinol. Metab. 92, 3958-3966 (2007).
17. Yen, S.S. Female hypogonadotropic hypogonadism. Hypothalamic amenorrhea syndrome. Endocrinol. Metab. Clin. North Am. 22, 29-58 (1993).
18. Reindollar, R.H., Novak, M., Tho, S.P. & Mcdonough, P.G. Adult-onset amenorrhea: a study of 262 patients. Am. J. Obstet. Gynecol. 155, 531-543 (1986).
19. Frisch, R.E. & Revelle, R. Height and weight at menarche and a hypothesis of critical body weights and adolescent events. Science 169, 397-399 (1970).
20. Laughlin, G.A., dominguez, c.E. & Yen, S.S. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea. J. Clin. Endocrinol. Metab. 83, 25-32 (1998).
21. Loucks, A.B., Verdun, M. & Heath, E.M. Low energy availability, not stress of exercise, alters LH pulsatility in exercising women. J. Appl. Physiol. 84, 37-46 (1998).
22. Marcus, M.d., Loucks, T.L. & Berga, S.L. Psychological correlates of functional hypothalamic amenorrhea. Fertil. Steril. 76, 310-316 (2001).
23. Reame, N.E., Sauder, S.E., Case, G.d., Kelch, R.P. & Marshall, J.c. Pulsatile gonadotropin secretion in women with hypothalamic amenorrhea: evidence that reduced frequency of gonadotropin-releasing hormone secretion is the mechanism of persistent anovulation. J. Clin. Endocrinol. Metab. 61, 851-858 (1985).
24. Castellano, J.M. et al. changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition. Endocrinology 146, 3917-3925 (2005).
25. Jayasena, c.N. et al. Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J. Clin. Endocrinol. Metab. 94, 4315-4323 (2009).
26. Seminara, S.B., dipietro, M.J., Ramaswamy, S., Crowley, W.F. Jr & Plant, T.M. continuous human metastin 45-54 influsion desensitizes G protein-coupled receptor 54-induced gonadotropin-releasing hormone release monitored indirectly in the juvenile male Rhesus monkey (Macaca mulatta): a fnding with therapeutic implications. Endocrinology 147, 2122-2126 (2006).
27. Cho, S.G. et al. Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation. Cancer Res. 69, 7062-7070 (2009).
28. Cho, S.G. et al. KiSS1 suppresses TNFα-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation. J. Cell. Biochem. 107, 1139-1149 (2009).
29. Roseweir, A.K. et al. discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation. J. Neurosci. 29, 3920-3929 (2009).
30. Yen, S.S., Rebar, R., Vandenberg, G., Ehara, Y. & Siler, T. Pituitary gonadotrophin responsiveness to synthetic LRF in subjects with normal and abnormal hypothalamic-pituitary-gonadal axis. J. Reprod. Fertil. Suppl. 20, 137-161 (1973).
31. Thompson, E.L. et al. chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats. Am. J. Physiol. Endocrinol. Metab. 291, E1074-E1082 (2006).
32. Tovar, S. et al. effects of single or repeated intravenous administration of kisspeptin upon dynamic LH secretion in conscious male rats. Endocrinology 147, 2696-2704 (2006).